BiomX (PHGE) Gains from Investment Securities (2023 - 2025)
BiomX (PHGE) posted Gains from Investment Securities of -$34000.0 for Q4 2025, up 26.09% sequentially from -$46000.0 in Q3 2025, and up 59.52% YoY from -$21313.4 in Q4 2024.
BiomX (PHGE) Gains from Investment Securities (2023 - 2025) Analysis & Trends
BiomX has reported Gains from Investment Securities for 3 years, with the latest figure at -$34000.0 in Q4 2025.
- Quarterly Gains from Investment Securities rose 59.52% year-over-year to -$34000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$77000.0 (up 99.76% YoY) and the FY2025 annual result came in at -$77000.0, up 1.28% from the prior year.
- Gains from Investment Securities rose to -$34000.0 in Q4 2025 per PHGE's latest filing, from -$46000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $7000.0 in Q4 2023 and troughed at -$20.6 million in Q3 2024.
- A 3-year average of -$3.6 million and a median of -$42000.0 in 2023 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2024 and 2025: Gains from Investment Securities plunged 48850.0% in 2024, then soared 100.01% in 2025.
- Over 3 years, Gains from Investment Securities stood at $7000.0 in 2023, then tumbled by 1300.0% to -$84000.0 in 2024, then surged by 59.52% to -$34000.0 in 2025.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered -$34000.0, -$46000.0, and $1000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | BiomX | 351,774.34 | -816,225.66 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -34,000.00 |
| Dec 31, 2025 | -34,000.00 |
| Sep 30, 2025 | -46,000.00 |
| Sep 30, 2025 | -46,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | -84,000.00 |
| Dec 31, 2024 | -84,000.00 |
| Sep 30, 2024 | -20.56 Mn |
| Sep 30, 2024 | -20.56 Mn |
| Jun 30, 2024 | -11.87 Mn |
| Jun 30, 2024 | -11.87 Mn |
| Dec 31, 2023 | 7,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2023 | -42,000.00 |
| Sep 30, 2023 | -42,000.00 |